World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02198027
Date of registration: 21/07/2014
Prospective Registration: No
Primary sponsor: Indus Hospital
Public title: Peritubal Infiltration of Bupivacaine in PCNL
Scientific title: Role of Peritubal Infiltration of 0.25% Bupivacaine in Percutaneous Nephrolithotomy (PCNL) in Postoperative Pain Control
Date of first enrolment: July 2014
Target sample size: 68
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT02198027
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Prevention  
Phase:  Phase 4
Countries of recruitment
Pakistan
Contacts
Name:     Zeeshan Arshad, MBBS
Address: 
Telephone:
Email: zeeshandaa@hotmail.com
Affiliation: 
Name:     Naila Baig-Ansari, PhD
Address: 
Telephone:
Email: naila.baig.ansari@gmail.com
Affiliation: 
Name:     Zafar Zaidi, MBBS
Address: 
Telephone:
Email:
Affiliation:  The Indus Hospital
Name:     Zeeshan Arshad, MBBS
Address: 
Telephone:
Email:
Affiliation:  The Indus Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- Age 18-60 years of age

- Single PCNL track

Exclusion Criteria:

- Spinal Disc Prolapse

- Any previous renal surgery

- Complication secondary to PCNL

- Hydrothorax that requires intervention

- Pneumothorax

- Massive hemorrhage that requires more than 1 U transfusion

- Conversion to open procedure.



Age minimum: 18 Years
Age maximum: 60 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Pain
Intervention(s)
Drug: Bupivacaine
Other: Normal saline infiltration
Primary Outcome(s)
Mean time for first demand of rescue analgesic [Time Frame: Release of the patient from the hospital or 24 hours (whichever comes first)]
Secondary Outcome(s)
Secondary ID(s)
IRD_IRB_2014_01_002
TIH-Urology-001
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history